<DOC>
	<DOCNO>NCT00000835</DOCNO>
	<brief_summary>The purpose trial determine safety immunogenicity HIV-1 pseudovirion vaccine give one antigen dose alone combination two different adjuvant use two immunization schedule . The pseudovirions virus-like particle generate vitro production HIV-1 viral protein capable assembly particle . The presence gag gene product addition envelope glycoprotein assist humoral cellular immunologic response internal HIV-1 viral protein . The pseudovirion vaccine test preclinical trial mouse , guinea pig , rabbit , nonhuman primate good safety immunogenicity profile .</brief_summary>
	<brief_title>A Multicenter , Randomized , Placebo-Controlled , Double-Blind Trial Evaluate Safety Immunogenicity HIV-1 Pseudovirion Vaccine</brief_title>
	<detailed_description>The pseudovirions virus-like particle generate vitro production HIV-1 viral protein capable assembly particle . The presence gag gene product addition envelope glycoprotein assist humoral cellular immunologic response internal HIV-1 viral protein . The pseudovirion vaccine test preclinical trial mouse , guinea pig , rabbit , nonhuman primate good safety immunogenicity profile . A total 78 volunteer recruit randomly assign receive pseudovirion vaccine and/or placebo/adjuvant . All volunteer receive injection intramuscularly 0 , 1 , 3 , 6 , 12 month . Group I ( 30 volunteer ) : pseudovirion vaccine w/adjuvant w/o adjuvant . Group II ( 30 volunteer ) : pseudovirion vaccine w/adjuvant w/o adjuvant . Group III ( 18 volunteer ) : adjuvant ( QS21 alum ) saline placebo . NOTE : Group I receive appropriate adjuvant saline placebo Month 3 without pseudovirion vaccine .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients must : Negative ELISA HIV1 antibody within 8 week initial immunization . CD4 count &gt; = 400 cells/mm3 . Negative Hepatitis B surface antigen . Normal history physical examination . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Medical psychiatric condition occupational responsibility preclude compliance protocol . Present psychosis . Active syphilis ( eligible serology document false positive due remote , i.e. , &gt; 6 month treat infection ) . Active tuberculosis ( eligible positive purify protein derivative test normal chest xray show evidence TB require isoniazid therapy ) . Hepatitis B antigenemia . Concurrent Medication : Excluded : Immunosuppressive medication . Patients follow prior condition exclude : History immunodeficiency , chronic illness , malignancy , autoimmune disease . History cancer unless surgical excision follow sufficient observation period give reasonable assurance cure . History suicide attempt , recent suicidal ideation past psychosis . History anaphylaxis serious adverse reaction vaccine . History serious allergic reaction substance , require hospitalization emergent medical care ( e.g . StevensJohnson syndrome , bronchospasm , hypotension ) . Prior Medication : Excluded : Prior receipt HIV1 vaccine placebo recipient previous HIV vaccine trial . Use experimental agent within 30 day prior study . Live attenuate vaccine within 60 day study . Medically indicated subunit kill vaccine ( e.g. , influenza , pneumococcal ) within 2 week prior study . Prior Treatment : Excluded : Receipt blood product immunoglobulin past 6 month . Risk Behavior : Excluded : Volunteers identifiable high risk behavior HIV infection determine screening question design identify risk factor HIV infection , specifically : History injection drug use within last 12 month prior enrollment . Higher intermediate risk sexual behavior define AVEG ( i.e. , meet criterion AVEG Risk Group C D ) . Volunteers risk behavior HIV infection determine upon information obtain questionnaire AIDS Vaccine Evaluation Group ( AVEG ) risk behavior guideline . NOTE : Only volunteer meet criterion AVEG Risk Groups A B enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>